New drug injection tested in fight against rare brain disorder
NCT ID NCT05819658
Summary
This study tested whether regular injections of an experimental drug called GV1001 could help slow the progression of Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. For 24 weeks, 78 patients in Korea received either one of two doses of GV1001 or a placebo (dummy) injection. Researchers measured changes in symptoms, thinking skills, and daily function to see if the drug was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE SUPRANUCLEAR PALSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kyung Hee University Hospital
Seoul, South Korea
-
Samsung Medical Center
Seoul, South Korea
-
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Seoul, South Korea
-
Seoul National University Bundang Hospital
Seongnam-si, South Korea
-
Seoul National University Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.